Breakfast and Lunchtime Symposiums

ANZBMS Therapeutics Breakfast Symposium 

Date: Monday 28th October 

Time: 7.30am to 9.00am (breakfast served from 7:00am)
Chairs: Bente Langdahl & Jasna Aleksova

Richard Prince
Update from the ANZBMS Therapeutics Committee.

Christian Girgis
Sclerostin Inhibitors in the Management of Osteoporosis: A New Dawn?

Emma Duncan
The hidden cost of cancer treatment: optimising bone health for women with breast cancer.

Craig Munns
Burosumab: role in management of X-linked hypophosphataemic rickets.


This Breakfast Symposium is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised by ANZBMS logo

 

   


AMGEN Lunchtime Symposium - Transitioning and sequencing osteoporosis treatments

Date: Monday 28th October 

Time: 12.00PM to 1.00pm (Lunch served outside of room from 11:45am)

Presenter: Professor Michael McClung

Panel discussion: Professor Peter Ebeling, Professor Michael McClung and Professor Bente Langdahl

This symposium offers the latest data on treating patients at risk of osteoporotic fracture. The following topics will be covered:

  • Treatment options: overview and update on the safety and efficacy data for anti-osteoporosis treatments, including long-term risk/benefit profiles.
  • Switching between therapies and treatment cessation, reversibility differences and off-treatment effects. 
  • Transitioning and sequencing treatment in practice – 30 min panel discussion

Chair: Professor Peter Ebeling AO, Head of the Department of Medicine in the School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences.

Presenter / panel member: Prof Michael McClung, founding director of the Oregon Osteoporosis Center, where he has had an active clinical practice, taken part in multiple educational initiatives and has been the principal investigator in many clinical trials evaluating the effects of therapeutic agents for osteoporosis and utility of tests for diagnosis and monitoring.

Panel member: Prof Bente Langdahl is a consultant at the department of Endocrinology and Internal Medicine at Aarhus University Hospital, Denmark and professor at Aarhus University. Prof Langdahl is past-President of the European Calcified Tissue Society and the co-chair of the International Federation for Musculoskeletal Research.

This lunchtime symposium is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised by Amgen Logo PNG Transparent


Our Sponsors